Search details
1.
Secondary analysis of late major gastrointestinal and genitourinary toxicities in unfavorable-risk prostate cancer patients receiving docetaxel: Insights from a randomized trial.
Cancer
; 2024 Mar 01.
Article
in English
| MEDLINE | ID: mdl-38427287
2.
Acute toxicity comparison of magnetic resonance-guided adaptive versus fiducial or computed tomography-guided non-adaptive prostate stereotactic body radiotherapy: A systematic review and meta-analysis.
Cancer
; 129(19): 3044-3052, 2023 10 01.
Article
in English
| MEDLINE | ID: mdl-37485697
3.
Cribriform morphology is associated with higher risk of biochemical recurrence after radical prostatectomy in patients with Grade Group 5 prostate cancer.
Histopathology
; 82(7): 1089-1097, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-36939057
4.
MR-guided prostate SBRT in prostate cancer patients with low-volume metastatic disease.
World J Urol
; 41(12): 3889-3894, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37924333
5.
Second malignancy probabilities in patients with prostate cancer treated with whole pelvis radiation therapy versus prostate only radiation therapy.
Prostate
; 82(11): 1098-1106, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35652585
6.
Prostate-specific antigen levels of ≤4 and >4 ng/mL and risk of prostate cancer-specific mortality in men with biopsy Gleason score 9 to 10 prostate cancer.
Cancer
; 127(13): 2222-2228, 2021 07 01.
Article
in English
| MEDLINE | ID: mdl-34101827
7.
Prostate-specific antigen nadir and testosterone level at prostate-specific antigen failure following radiation and androgen suppression therapy for unfavorable-risk prostate cancer and the risk of all-cause and prostate cancer-specific mortality.
Cancer
; 127(15): 2623-2630, 2021 08 01.
Article
in English
| MEDLINE | ID: mdl-33823065
8.
Decision Making in Prostate Cancer.
N Engl J Med
; 389(14): 1335-1338, 2023 Oct 05.
Article
in English
| MEDLINE | ID: mdl-37792620
9.
Clinicopathological and molecular characteristics of prostate cancer diagnosed in young men aged up to 45 years.
Histopathology
; 78(6): 857-870, 2021 May.
Article
in English
| MEDLINE | ID: mdl-33306242
10.
Progress and controversies: Radiation therapy for prostate cancer.
CA Cancer J Clin
; 64(6): 389-407, 2014.
Article
in English
| MEDLINE | ID: mdl-25234700
11.
Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012.
Cancer
; 126(4): 717-724, 2020 02 15.
Article
in English
| MEDLINE | ID: mdl-31794057
12.
Alcohol Use Among Patients With Cancer and Survivors in the United States, 2000-2017.
J Natl Compr Canc Netw
; 18(1): 69-79, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31910381
13.
A Bayesian multi-risks survival (MRS) model in the presence of double censorings.
Biometrics
; 76(4): 1297-1309, 2020 12.
Article
in English
| MEDLINE | ID: mdl-31994171
14.
Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance.
JAMA
; 324(17): 1747-1754, 2020 11 03.
Article
in English
| MEDLINE | ID: mdl-33141207
15.
Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database.
Cancer
; 125(19): 3338-3346, 2019 10 01.
Article
in English
| MEDLINE | ID: mdl-31251398
16.
Adjuvant and Salvage Radiotherapy after Prostatectomy: ASTRO/AUA Guideline Amendment 2018-2019.
J Urol
; 202(3): 533-538, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31042111
17.
Combined External Beam Radiation Therapy and Brachytherapy versus Radical Prostatectomy with Adjuvant Radiation Therapy for Gleason 9-10 Prostate Cancer.
J Urol
; 202(5): 973-978, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31144590
18.
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 17(5): 479-505, 2019 05 01.
Article
in English
| MEDLINE | ID: mdl-31085757
19.
Impact of time to testosterone rebound and comorbidity on the risk of cause-specific mortality in men with unfavorable-risk prostate cancer.
Cancer
; 124(7): 1391-1399, 2018 04 01.
Article
in English
| MEDLINE | ID: mdl-29338073
20.
Low testosterone at first prostate-specific antigen failure and assessment of risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials.
Cancer
; 124(7): 1383-1390, 2018 04 01.
Article
in English
| MEDLINE | ID: mdl-29266181